76961-101 : Rolvedon 13.2 mg/.6ml Subcutaneous Injection, Solution
NDC: | 76961-101 |
Labeler: | Spectrum Pharmaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Rolvedon |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | BLA761148 |
Rev. Date: |
NDC Package Codes:
- 76961-101-01: .6 ML IN 1 SYRINGE, GLASS (76961‑101‑01)
Active Ingredients:
- Eflapegrastim
Dosage Strength:
- 13.2 mg/.6mL
Pharmaceutical Classes:
- Granulocyte Colony-Stimulating Factor [CS]
- Increased Myeloid Cell Production [PE]
- Leukocyte Growth Factor [EPC]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 76944-123Next: 76964-101 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.